MAP1S and nonpapillary renal cell carcinoma: Previously, we found that levels of MAP1S are dramatically reduced in renal tissues from patients suffering with ccRCC and established that the impairment of MAP1S-mediated autophagy turnover of lipid droplets leads to the development of ccRCC [27].